Sodium Chloride Injection Recalled for Incomplete Seal and Potential Leakage
B. Braun Medical is recalling 0.9% Sodium Chloride Injection due to possible incomplete container seals that may leak. The recall involves 483,229 bags distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: No illnesses or hospitalizations are reported in the source. This is an FDA Class II recall with a theoretical hazard (incomplete seals 'may' cause leakage) and no confirmed harm, consistent with 'risk-of-harm products where injury has not yet been reported.'
Plain-English summary
B. Braun Medical Inc. is recalling certain batches of 0.9% Sodium Chloride Injection, USP, in 500 mL Excel Plus containers. These products are used for intravenous infusion. The recall affects 483,229 bags distributed nationwide.
The recall is due to lack of sterility assurance. Some batches may have incomplete seals near the port assembly, potentially causing microscopic channel leaks. If the seal is compromised, the product's sterility cannot be assured.
Affected lot numbers are: 0061794230 (exp. 01/31/2024), 0061794232 (exp. 01/31/2024), 0061797779 (exp. 02/29/2024), 0061797780 (exp. 02/29/2024), 0061797781 (exp. 02/29/2024), 0061797783 (exp. 02/29/2024), 0061797784 (exp. 03/31/2024), 0061797785 (exp. 03/31/2024), 0061797786 (exp. 03/31/2024), 0061797787 (exp. 03/31/2024), 0061797788 (exp. 03/31/2024), and 0061809680 (exp. 04/30/2024).
Healthcare facilities, pharmacies, and patients should immediately check for these lot numbers. Inventory from affected lots should not be used. Patients who may have received infusions from these batches should contact their healthcare provider.
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- B. Braun Medical Inc.
- Category
- Drug — Intravenous Injectable
- Hazard
- incomplete-seal
- leakage
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lots: 0061794230 Exp. 01/31/2024
- 0061794232 Exp. 01/31/2024
- 0061797779 Exp. 02/29/2024
- 0061797780 Exp. 02/29/2024
- 0061797781 Exp. 02/29/2024
- 0061797783 Exp. 02/29/2024
- 0061797784 Exp. 03/31/2024
- 0061797785 Exp. 03/31/2024
- 0061797786 Exp. 03/31/2024
- 0061797787 Exp. 03/31/2024
- 0061797788 Exp. 03/31/2024
- 0061809680 Exp. 04/30/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SODIUM CHLORIDE
- HighInjectable Sodium Chloride Ampules Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-04-22
- HighInjectable Sodium Chloride Recalled Due to Sterility Assurance Issue
FDA (Drugs) · 2026-04-15
- HighInjectable Sodium Chloride Recall Due to Sterility Assurance Issue
FDA (Drugs) · 2026-04-15
- HighSodium chloride intravenous injection recalled for lack of sterility assurance
FDA (Drugs) · 2026-04-15
- HighSodium Chloride IV Injection Recall for Sterility Assurance Concerns
FDA (Drugs) · 2026-04-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27